High Dose Chemotherapy Followed By PBSC Rescue for HD

Use of High Dose Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Relapsed or Resistant Hodgkin's Disease

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00186251

Enrollment

200

Registered

2005-09-16

Start date

1998-03-31

Completion date

2005-07-31

Last updated

2012-11-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hodgkin Disease

Brief summary

To evaluate the role of high dose chemotherapy with autologous hematopoietic cell transplantation in the treatment of Hodgkin's Disease.

Detailed description

Use of High Dose Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Relapsed or Resistant Hodgkin's Disease

Interventions

PROCEDUREhigh dose chemo then auto hematopoietic cell transplant

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

4 Weeks to 70 Years

Healthy volunteers

Inclusion criteria

- adequate organ function * recurrent HD

Exclusion criteria

- CNS disease * no prior malignancy

Design outcomes

Primary

Measure	Time frame
Overall survival	—
FFS	—
Response rates	—

Secondary

Measure	Time frame
Toxicity of high dose chemotherapy	—

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026